InvestorsHub Logo
Followers 74
Posts 15841
Boards Moderated 0
Alias Born 04/26/2010

Re: Birdbrain Ideas post# 351765

Wednesday, 08/25/2021 3:41:17 PM

Wednesday, August 25, 2021 3:41:17 PM

Post# of 425975
I think the point about a biotech like AMRN at this point in it's life rarely being BO is accurate - a one drug company with stagnant US sales - time to BO was right before or right after R-IT results, but JT wasn't willing to listen to offers - even when they were addressing EU sales he said they weren't looking for a BO, they were looking for a partner. After the Dubacle there's even less reason for a BO - where have you ever seen a BO where generic competition existed in the US?

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News